Newsletter

Nordic moderna suspends vaccination of young people… Authorities “continue to observe” (comprehensive)

Citizens who were vaccinated at the Novel Coronavirus Infectious Disease (COVID-19) Vaccine Vaccination Center at the Bukahyeon Culture and Sports Center in Seodaemun-gu, Seoul on the 5th are waiting in the adverse reaction monitoring area. 2021.10.5/News 1 © News1 Reporter Lim Se-young

The quarantine authorities said they would continue to monitor (observe) the restrictions on the moderna vaccine for young people in some countries in northern Europe.

Recently, Nordic countries, such as Denmark and Sweden, temporarily suspended moderna COVID-19 vaccinations for young people until December due to myocarditis and pericarditis.

Jeong-ik Hong, head of the vaccination management team, said in an online back briefing of the reporters on the 8th, “In Korea, children and adolescents aged 12 to 17 are vaccinated only with Pfizer vaccine,” but he will continue to monitor the situation in other countries.

According to foreign media, the countries that have stopped Moderna include Sweden, Denmark, Norway and Finland. This is why the incidence of myocarditis and pericarditis among adolescents and young adults is higher than that of the Pfizer vaccine.

Team leader Hong explained, “There are some concerns about immunizations for children and adolescents due to the suspension of vaccination in northern European countries,” and explained that it has nothing to do with Korea.

“There is no change in the position of the United States and the European Union,” he added. “We will monitor international trends and, if necessary, respond to policies based on expert advice and opinions.

However, in Northern Europe, there are countries that have banned vaccination for those under the age of 30 in addition to those under the age of 18.

Some critical questions also followed, such as whether modernity or the age limit for vaccination cannot be judged on their own, and why it is necessary to follow the decision of the US or the EU to make a follow-up decision.

Team leader Hong said, “It was announced only two days ago, so there are no plans to change the standards of our country by holding an expert committee yet.” He continued, “All humans need to be judged on the basis of scientific universality that is applied in common, and the US and EU are regions where large-scale studies are being conducted and the number of actual vaccinations is the highest.” I made a decision,” he said.

There were also questions about the expansion of home treatment announced on the same day. When asked whether there must be one guardian or both parents are guardians when children and adolescents receive home treatment, he said, “In principle, there is one guardian to minimize the risk of further infection, but it may be difficult with only one person depending on the patient’s circumstances, so it is exceptional. to allow additional guardians.”

In addition, when asked how they view the risk of infection of those who live with them during home treatment, he said, “There may be guardians and other people living with the home caregiver. No. In principle, they must be inoculated to minimize the risk of infection.”

On the other hand, from the 9th, the authorities allowed to change the reservation for the second dose of Moderna to 4 to 6 weeks by one week from the previous 5 to 6 weeks.

ungaungae@news1.kr